CYduct Diagnostics, Inc.
CYDX · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1,059 | $797 | $2,788 |
| - Cash | $1 | $4 | $28 | $5 |
| + Debt | $628 | $715 | $716 | $669 |
| Enterprise Value | – | $1,770 | $1,485 | $3,452 |
| Revenue | $24 | $17 | $19 | $11 |
| % Growth | 45.5% | -13% | 74.5% | – |
| Gross Profit | $15 | $11 | $13 | $8 |
| % Margin | 62.5% | 65.8% | 68.9% | 70.1% |
| EBITDA | -$82 | -$100 | -$75 | -$102 |
| % Margin | -340.2% | -603.9% | -394.2% | -935.1% |
| Net Income | -$95 | -$113 | -$88 | -$114 |
| % Margin | -394.2% | -681.4% | -461.8% | -1,041.6% |
| EPS Diluted | -0.018 | -0.022 | -0.017 | -0.022 |
| % Growth | 15.7% | -28.6% | 22.6% | – |
| Operating Cash Flow | -$2 | -$23 | -$24 | -$23 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$23 | -$24 | -$23 |